Trademark: 97392621
Word
LEGHENLA
Status
Dead
Status Code
606
Status Date
Monday, November 6, 2023
Serial Number
97392621
Mark Type
4000
Filing Date
Tuesday, May 3, 2022
Published for Opposition
Tuesday, February 7, 2023
Abandoned Date
Monday, November 6, 2023

Trademark Owner History
Pfizer Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; human growth hormones

Trademark Events
Nov 6, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 6, 2023
Abandonment - No Use Statement Filed
Apr 4, 2023
Noa E-Mailed - Sou Required From Applicant
Mar 27, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 27, 2023
Teas Change Of Correspondence Received
Mar 27, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 27, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 27, 2023
Teas Change Of Owner Address Received
Feb 7, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 7, 2023
Published For Opposition
Jan 18, 2023
Notification Of Notice Of Publication E-Mailed
Jan 4, 2023
Approved For Pub - Principal Register
Jan 4, 2023
Assigned To Examiner
May 6, 2022
New Application Office Supplied Data Entered
May 6, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24